Abstract
COVID-19 has caused an unprecedented healthcare crisis, which has taken a toll on frontline clinicians (FC) [1,2], The MassGeneral Brigham (MGB) hospital system launched an FC resiliency group program and assessed its feasibility, acceptability, and efficacy. Upon IRB approval, English-speaking FCs were recruited (3/23/20–6/02/20) for 17 groups, and completed optional pre and post-treatment surveys. The treatment, previously assessed in caregivers and clinicians, was grounded in relaxation response elicitation, mindfulness, cognitive behavioral therapy, and positive psychology [3,4] and adapted for FCs (health and job uncertainty, clinical role transitions, isolation, and financial and family challenges). Program delivery was modified to eight 1-h biweekly sessions via a HIPAA compliant synchronous videoconferencing platform. Groups were co-facilitated by MGB staff trained in the Stress Management and Resiliency Training-Relaxation Response Program (SMART-3RP) delivery, offered at flexible times, and organized according to FC specialty. Group facilitators attended biweekly clinical supervision, documented attendance, and completed treatment fidelity checklists. No serious adverse events were reported.